Privacy Policy
Signals Blog

Contributors

Categories

Right Turn: Out of the bubble with gene-edited stem cells

> This is a rather exciting time to be in the stem cell and regenerative medicine field and one of the main reasons for this is the number of announcements and articles about clinical trials taking place. Seven years ago, when I joined the Stem Cell Network, these...

Lessons from Dendreon

. You have all by now heard that Dendreon has filed for bankruptcy protection. If you’re a regular reader of Signals, you may have first heard the news here. While the company has successfully reached agreements on a financial restructuring with a majority of its...

Right Turn: New StemCellShorts illuminates cancer stem cells

> Just over one year ago, we launched the pilot phase of an animation project titled StemCellShorts here on Signals blog. Funded by a Stem Cell Network Public Outreach Award, the project was very much an experiment for us to see what would happen when you tasked a...

Right Turn: Get an earful of stem cells

> There are a multitude of ways to stay informed about research trends and advances in the field. Obvious ones, for a researcher or trainee are lab or journal club meetings, conferences, or journal subscriptions. Then there’s the online world, including any...